PMC:7003341 / 69262-69727 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T188","span":{"begin":122,"end":126},"obj":"Disease"},{"id":"T189","span":{"begin":422,"end":426},"obj":"Disease"}],"attributes":[{"id":"A188","pred":"mondo_id","subj":"T188","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A189","pred":"mondo_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"However, neuromuscular blockade through continuous infusion should not be routinely used in patients with moderate-severe ARDS; Where available, ECMO in conjunction with low tidal-volume mechanical ventilation can be considered in the treatment of patients with severe refractory hypoxemia in whom standard therapy are failing; Routine use of high-frequency oscillatory ventilation (HFOV) in patients with moderate-severe ARDS is not beneficial, but may be harmful."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T186","span":{"begin":280,"end":289},"obj":"Phenotype"}],"attributes":[{"id":"A186","pred":"hp_id","subj":"T186","obj":"http://purl.obolibrary.org/obo/HP_0012418"}],"text":"However, neuromuscular blockade through continuous infusion should not be routinely used in patients with moderate-severe ARDS; Where available, ECMO in conjunction with low tidal-volume mechanical ventilation can be considered in the treatment of patients with severe refractory hypoxemia in whom standard therapy are failing; Routine use of high-frequency oscillatory ventilation (HFOV) in patients with moderate-severe ARDS is not beneficial, but may be harmful."}

{"project":"LitCovid-sentences","denotations":[{"id":"T543","span":{"begin":0,"end":465},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"However, neuromuscular blockade through continuous infusion should not be routinely used in patients with moderate-severe ARDS; Where available, ECMO in conjunction with low tidal-volume mechanical ventilation can be considered in the treatment of patients with severe refractory hypoxemia in whom standard therapy are failing; Routine use of high-frequency oscillatory ventilation (HFOV) in patients with moderate-severe ARDS is not beneficial, but may be harmful."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1240","span":{"begin":92,"end":100},"obj":"Species"},{"id":"1241","span":{"begin":248,"end":256},"obj":"Species"},{"id":"1242","span":{"begin":392,"end":400},"obj":"Species"},{"id":"1252","span":{"begin":122,"end":126},"obj":"Disease"},{"id":"1253","span":{"begin":280,"end":289},"obj":"Disease"},{"id":"1254","span":{"begin":422,"end":426},"obj":"Disease"}],"attributes":[{"id":"A1240","pred":"tao:has_database_id","subj":"1240","obj":"Tax:9606"},{"id":"A1241","pred":"tao:has_database_id","subj":"1241","obj":"Tax:9606"},{"id":"A1242","pred":"tao:has_database_id","subj":"1242","obj":"Tax:9606"},{"id":"A1252","pred":"tao:has_database_id","subj":"1252","obj":"MESH:D012128"},{"id":"A1253","pred":"tao:has_database_id","subj":"1253","obj":"MESH:D000860"},{"id":"A1254","pred":"tao:has_database_id","subj":"1254","obj":"MESH:D012128"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"However, neuromuscular blockade through continuous infusion should not be routinely used in patients with moderate-severe ARDS; Where available, ECMO in conjunction with low tidal-volume mechanical ventilation can be considered in the treatment of patients with severe refractory hypoxemia in whom standard therapy are failing; Routine use of high-frequency oscillatory ventilation (HFOV) in patients with moderate-severe ARDS is not beneficial, but may be harmful."}